Swissmedic
REGULATORY UPDATE
Protection against designer drugs: Further psychoactive substances prohibited
Published: 3/13/2026Detected: 3/26/2026
Summary preview
Prohibits additional psychoactive substances to strengthen protections against designer drugs. The update likely expands the list of banned substances and may trigger compliance actions for products or ingredients…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Extended deadline for publishing officially mandated information materials on the electronic publication platform11/12/2026
- Designer drugs: FDHA brings further psychoactive substances under control11/10/2026
- NAD+ supplements: When lifestyle products have criminal consequences11/9/2026
- Publication eCTD v4.0 Implementation Guide Package v2.011/9/2026
- Save the Date: Clinical Trials Symposium 202711/4/2026